Half of advanced melanoma patients live for 10 years with double drug treatment The GuardianNew skin cancer treatment helps patients live 10 years after diagnosis, study finds The TelegraphBristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit with Opdivo® plus Yervoy® in Advanced Melanoma BioSpaceNeoadjuvant Immunotherapy Superior to Targeted Therapy in Stage III Melanoma AJMC.com Managed Markets Network